G. A. Rodan and T. J. Martin, Therapeutic Approaches to Bone Diseases, Science, vol.289, issue.5484, pp.1508-1514, 2000.
DOI : 10.1126/science.289.5484.1508

M. Baud-'huin, L. Duplomb, C. R. Velasco, Y. Fortun, D. Heymann et al., Key roles of the OPG-RANK-RANKL system in bone oncology, Expert. Rev. Anticancer. Ther, vol.7, pp.221-232, 2007.

M. Baud-'huin, N. Solban, M. Cornwall-brady, D. Sako, Y. Kawamoto et al., A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.12207-12212, 2012.

M. Zaidi, Skeletal remodeling in health and disease, Nature Medicine, vol.312, issue.7, pp.791-801, 2007.
DOI : 10.7326/0003-4819-134-7-200104030-00009

P. Vrtacnik, J. Marc, and B. Ostanek, Epigenetic mechanisms in bone, Clinical Chemistry and Laboratory Medicine, vol.52, issue.5, pp.589-608, 2014.
DOI : 10.1515/cclm-2013-0770

Y. Liu, X. Zhang, L. Chen, X. Lin, D. Xiong et al., Epigenetic mechanisms of bone regeneration and homeostasis, Progress in Biophysics and Molecular Biology, vol.122, issue.2, 2016.
DOI : 10.1016/j.pbiomolbio.2016.01.005

D. S. Hewings, T. P. Rooney, L. E. Jennings, D. Hay, S. Cj et al., Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain???Acetyl-lysine Interactions, Journal of Medicinal Chemistry, vol.55, issue.22, 2012.
DOI : 10.1021/jm300915b

R. K. Prinjha, J. Witherington, and K. Lee, Place your BETs: the therapeutic potential of bromodomains, Trends in Pharmacological Sciences, vol.33, issue.3, pp.146-153, 2012.
DOI : 10.1016/j.tips.2011.12.002

T. D. Beinke, E. J. Chapman, P. E. Roberts, K. R. Soden, O. Auger et al., Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia, Nature, vol.478, pp.529-533, 2011.

P. Filippakopoulos, J. Qi, S. Picaud, Y. Shen, W. B. Smith et al., Selective inhibition of BET bromodomains, Nature, vol.4, issue.7327, pp.1067-1073, 2010.
DOI : 10.1016/S0002-9440(10)63049-0

F. Lamoureux, M. Baud-'huin, L. Rodriguez-calleja, C. Jacques, M. Berreur et al., Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle, Nature Communications, vol.128, p.3511, 2014.
DOI : 10.1002/ijc.25776

J. Zuber, J. Shi, E. Wang, A. R. Rappaport, H. Herrmann et al., RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia, Vakoc, RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia, pp.524-528, 2011.
DOI : 10.2144/000112297

I. A. Asangani, V. L. Dommeti, X. Wang, R. Malik, M. Cieslik et al., Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer, Nature, vol.8, issue.7504, pp.278-282, 2014.
DOI : 10.1371/journal.pone.0063563

K. H. Park-min, E. Lim, M. J. Lee, S. H. Park, E. Giannopoulou et al., Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation, Nature Communications, vol.5, issue.5418, 2014.
DOI : 10.1016/j.bmcl.2012.01.125

S. Meng, L. Zhang, Y. Tang, Q. Tu, L. Zheng et al., BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction, Journal of Dental Research, vol.2000, issue.7, pp.93-657, 2014.
DOI : 10.1038/nature10334
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107547/pdf

B. Gjoksi, C. Ghayor, B. Siegenthaler, N. Ruangsawasdi, M. Zenobi-wong et al., The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis, Bone, vol.78, pp.114-121, 2015.
DOI : 10.1016/j.bone.2015.05.004

B. Brounais, C. Chipoy, K. Mori, C. Charrier, S. Battaglia et al., Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of Midostaurin In vivo, Clinical Cancer Research, vol.14, issue.17, pp.5400-5409, 2008.
DOI : 10.1158/1078-0432.CCR-07-4781

B. Gobin, M. B. Huin, F. Lamoureux, B. Ory, C. Charrier et al., BYL719, a new ??-specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma, International Journal of Cancer, vol.70, issue.Supp 1, pp.784-796, 2015.
DOI : 10.1158/0008-5472.CAN-09-4172
URL : https://hal.archives-ouvertes.fr/inserm-01644799

L. Duplomb, M. Baud-'huin, C. Charrier, M. Berreur, V. Trichet et al., Phosphorylation of Signal Transducer and Activator of Transcription 3, Endocrinology, vol.149, issue.7, pp.3688-3697, 2008.
DOI : 10.1210/en.2007-1719
URL : https://hal.archives-ouvertes.fr/inserm-00667501

C. Chipoy, M. Berreur, S. Couillaud, G. Pradal, F. Vallette et al., Downregulation of Osteoblast Markers and Induction of the Glial Fibrillary Acidic Protein by Oncostatin M in Osteosarcoma Cells Require PKC?? and STAT3, Journal of Bone and Mineral Research, vol.100, issue.Suppl, pp.1850-1861, 2004.
DOI : 10.4049/jimmunol.171.6.3202

V. Trichet, C. Benezech, C. Dousset, M. C. Gesnel, M. Bonneville et al., Complex Interplay of Activating and Inhibitory Signals Received by V??9V??2 T Cells Revealed by Target Cell ??2-Microglobulin Knockdown, The Journal of Immunology, vol.177, issue.9, pp.6129-6136, 2006.
DOI : 10.4049/jimmunol.177.9.6129

H. Takayanagi, The Role of NFAT in Osteoclast Formation, Annals of the New York Academy of Sciences, vol.1116, issue.1, pp.1116-227, 2007.
DOI : 10.1196/annals.1402.071

L. B. Ivashkiv, Metabolic-epigenetic coupling in osteoclast differentiation, Nature Medicine, vol.159, issue.3, pp.212-213, 2015.
DOI : 10.1016/j.cell.2014.11.018
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795459/pdf

T. Yasui, J. Hirose, H. Aburatani, and S. Tanaka, Epigenetic regulation of osteoclast differentiation, Annals of the New York Academy of Sciences, vol.26, issue.Suppl, pp.1240-1247, 2011.
DOI : 10.1002/jbmr.357

A. Chaidos, V. Caputo, and A. Karadimitris, Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence, Therapeutic Advances in Hematology, vol.31, issue.21, pp.128-141, 2015.
DOI : 10.1038/nature10334

J. A. Mertz, A. R. Conery, B. M. Bryant, P. Sandy, S. Balasubramanian et al., Targeting MYC dependence in cancer by inhibiting BET bromodomains, Proceedings of the National Academy of Sciences, vol.107, issue.20, pp.16669-16674, 2011.
DOI : 10.1016/S0065-230X(10)07006-5
URL : http://www.pnas.org/content/108/40/16669.full.pdf

J. E. Delmore, G. C. Issa, M. E. Lemieux, P. B. Rahl, J. Shi et al., BET Bromodomain Inhibition as??a Therapeutic Strategy to Target c-Myc, Bradner, C.S. Mitsiades, BET bromodomain inhibition as a therapeutic strategy to target c-Myc, pp.904-917, 2011.
DOI : 10.1016/j.cell.2011.08.017
URL : https://doi.org/10.1016/j.cell.2011.08.017

C. J. Ott, N. Kopp, L. Bird, R. M. Paranal, J. Qi et al., BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia, Blood, vol.120, issue.14, 2012.
DOI : 10.1182/blood-2012-02-413021
URL : http://www.bloodjournal.org/content/bloodjournal/120/14/2843.full.pdf

M. A. Karsdal, T. J. Martin, J. Bollerslev, C. Christiansen, and K. Henriksen, Are Nonresorbing Osteoclasts Sources of Bone Anabolic Activity?, Journal of Bone and Mineral Research, vol.349, issue.S1, pp.22-487, 2007.
DOI : 10.1172/JCI0215687

J. Bollerslev, T. Steiniche, F. Melsen, and L. Mosekilde, Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: A study of two radiological types, Bone, vol.10, issue.1, pp.19-24, 1989.
DOI : 10.1016/8756-3282(89)90142-7

J. Bollerslev, S. C. Marks-jr, S. Pockwinse, M. Kassem, K. Brixen et al., Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis, Bone, vol.14, issue.6, pp.865-869, 1993.
DOI : 10.1016/8756-3282(93)90316-3

M. M. Matzuk, M. R. Mckeown, P. Filippakopoulos, Q. Li, L. Ma et al., Small-Molecule Inhibition of BRDT for Male Contraception, Cell, vol.150, issue.4, pp.673-684, 2012.
DOI : 10.1016/j.cell.2012.06.045

J. Shi and C. R. Vakoc, The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition, Molecular Cell, vol.54, issue.5, pp.728-736, 2014.
DOI : 10.1016/j.molcel.2014.05.016

P. J. Marie, Bone Cell Senescence: Mechanisms and Perspectives, Journal of Bone and Mineral Research, vol.5, issue.2, pp.1311-1321, 2014.
DOI : 10.18632/aging.100531
URL : http://onlinelibrary.wiley.com/doi/10.1002/jbmr.2190/pdf